Metergoline

Metergoline

SCHEMBL117882

CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 5/20 1.00
CYP2D6 P10635 4/20 1.00
HTR7 P34969 3/20 1.00
HTR6 P50406 3/20 1.00
HTR2A P28223 3/20 1.00
MEN1 O00255 2/20 1.00
USP2 O75604 2/20 1.00
TP53 P04637 2/20 1.00
CYP3A4 P08684 2/20 1.00
MAPT P10636 2/20 1.00
TSHR P16473 2/20 1.00
CYP2C19 P33261 2/20 1.00
KMT2A Q03164 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
CYP1A2 P05177 2/20 1.00
RGS12 O14924 2/20 1.00
GNAI1 P63096 2/20 1.00
KDM4E B2RXH2 2/20 1.00
LMNA P02545 2/20 1.00
PMP22 Q01453 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metergoline SCHEMBL19236127 1.00 HTR2B (1.00) HTR2BCYP2D6HTR7HTR6HTR2A
Metergoline SCHEMBL7631854 1.00 HTR2B (1.00) HTR2BCYP2D6HTR7HTR6HTR2A
Metergoline SCHEMBL15440536 1.00 HTR2B (1.00) HTR2BCYP2D6HTR7HTR6HTR2A
Metergoline SCHEMBL29392365 1.00 HTR2B (1.00) HTR2BCYP2D6HTR7HTR6HTR2A
SCHEMBL8209067 0.92 HTR2B (0.84) HTR2BCYP2D6HTR7HTR6HTR2A
SCHEMBL11724011 0.89 HTR2B (0.80) HTR2BCYP2D6HTR7HTR6HTR2A
SCHEMBL20013753 0.88 HTR2B (0.79) HTR2BCYP2D6HTR7HTR6HTR2A
SCHEMBL2526351 0.86 HTR2B (0.76) HTR2BCYP2D6HTR7HTR6HTR2A
Metergoline SCHEMBL15821685 0.85 CYP2D6 (0.72) HTR2BCYP2D6HTR7HTR6HTR2A
Metergoline SCHEMBL3714712 0.85 CYP2D6 (0.72) HTR2BCYP2D6HTR7HTR6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3182 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4674894-A2 COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES Hemoteq AG (DE) 2026-01-07 EP claimed
EP-4663688-A2 CROSSLINKERS Hemoteq AG (DE) 2025-12-17 EP claimed
US-20250295611-A1 METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS TESSELLATE THERAPEUTICS INC (US) 2025-09-25 US claimed
EP-4547250-A1 METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS Terran Biosciences Inc. (US) 2025-05-07 EP claimed
US-20250090566-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2025-03-20 US claimed
CN-119506289-A Aptamer combination suitable for single-cell sequencing and application of aptamer combination in construction of biliary tract cancer cell patterns 中国科学院杭州医学研究所 2025-02-25 CN claimed
US-20250049748-A1 ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE TERRAN BIOSCIENCES INC (US) 2025-02-13 US claimed
WO-2024189607-A1 METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT DIDENKO KIRILL (MX) 2024-09-19 WO claimed
US-20240245693-A1 COMPOSITIONS AND METHODS OF TISSUE REGENERATION THERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-07-25 US claimed
US-20240197681-A1 METHODS AND COMPOSITIONS RELATING TO PSYCHEDELICS AND SEROTONIN RECEPTOR MODULATORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-06-20 US claimed
CN-1082891-A Technology for raising poultry UNIV NANJING AGRICULTURAL (CN) 1994-03-02 CN claimed
WO-1993024144-A1 PREPARATION FOR ACTIVATION OF NATURAL KILLER CELLS (NK-CELLS), SAID PREPARATION CONTAINING INTERFERON-α AND HISTAMINE, SEROTONIN OR SUBSTANCES WITH CORRESPONDING RECEPTOR ACTIVITY SYNTELLO INC. (US) 1993-12-09 WO claimed
EP-0440704-A1 COMPOSITIONS FOR TREATING TOBACCO WITHDRAWEL SYMPTOMS. MASSACHUSETTS INST TECHNOLOGY (US) 1991-08-14 EP claimed
EP-0440333-A2 Dopamine agonists for treating type II diabetes LOUISIANA STATE UNIVERSITY AGRICULTURAL AND MECHANICAL COLLEGE (US) 1991-08-07 EP claimed
EP-0386117-A1 TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1990-09-12 EP claimed
WO-1990004387-A2 COMPOSITIONS FOR TREATING TOBACCO WITHDRAWAL SYMPTOMS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1990-05-03 WO claimed
WO-1989003692-A1 TREATING PREMENSTRUAL OR LATE LUTEAL PHASE SYNDROME MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-05-05 WO claimed
EP-0231151-A2 Immunosuppressant agents SANDOZ AG (CH) 1987-08-05 EP claimed
US-4444778-A ANTISEROTONINE AGENTS COUGHLIN SHAUN R 1984-04-24 US claimed
US-4151283-A 6-Methyl-and 1,6-dimethyl-8β-carbobenzyloxy-aminomethyl-10α-ergoline as inhibitors of prolactin secretion SOCIETA' FARMACEUTICI ITALIA S.P.A. (IT) 1979-04-24 US claimed